Policy / Pricing UK commits to pharma IP protection in Swiss trade deal Pharmaceutical TechnologyThe pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreementRead full story pharminent July 16, 2026 (Last updated: July 20, 2026) Pharmaceutical Technology The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA Approves At-Home Leqembi for Early Alzheimer’s DiseaseNext: Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra Related Stories Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026 Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026
